glp-1
(7)
Elliott Green
Elliott Green is the co-founder and CEO of Dandelion Health, a New York-based real-world data and clinical AI platform building multimodal, longitudinal datasets from a consortium of non-academic health systems. A former founding member of Oscar Health with a finance background, Green launched Dandelion in 2020 to give life science companies and AI developers unbiased, clinical-grade data - including the images, waveforms, and notes that make up most of medicine but are rarely used. The company closed a $14M Series A in 2026 and has launched a free AI validation service and a GLP-1 data library aimed at bringing precision medicine to cardiometabolic disease.
James O'Mara
James (Jim) O'Mara is the President and CEO of Neurogastrx, a Woburn, Massachusetts specialty pharmaceutical company developing oral therapies for gastrointestinal disorders. A pharmacist by training with decades in biotech, he was one of the original members of the LINZESS team at Ironwood Pharmaceuticals, where he rose to Senior Vice President of Corporate Development and drove licensing deals across the U.S., Europe, Japan and China. At Neurogastrx he raised a $60 million Series B and is steering the company's lead candidate, NG101, through clinical studies aimed at the nausea and vomiting that lead many patients to abandon GLP-1 weight-loss and diabetes medicines.
Noah Kotlove
Noah Kotlove is the co-founder and CEO of Berry Street, a New York-based telehealth platform that connects patients with insurance-covered registered dietitians and gives independent RDs the software to run their practices. He launched Berry Street in 2023 with Jesse Rose after his own experience with a dietitian led to sustained results where fad diets had not. Before Berry Street, Kotlove built Sobrietysoft, an addiction recovery app that grew to more than six million users, and worked as a senior innovation consultant at Accenture after graduating from Wharton. In February 2025 Berry Street raised a $50M Series B led by Northzone, with Sofina, FJ Labs, the founder of Revolut, the co-founders of Spring Health and Grow Therapy, and the CEO of Found also participating.
Sandy Mou
Sandy Mou, MD, is the Chief Executive Officer and Board Executive Director of CORXEL Pharmaceuticals, a New Jersey- and Shanghai-linked biotech developing an oral small molecule GLP-1 receptor agonist for obesity and diabetes. A Fudan-trained clinician turned pharma executive with nearly three decades at GSK, AstraZeneca, Johnson & Johnson, and MSD, she led MSD China's oncology unit into the country's top three within three years and later took Shanghai Allist public on the STAR Market before joining JIXING - now CORXEL - in early 2023.
Peter DiLaura
Peter DiLaura is the CEO and Board Director of Helicore Biopharma, a San Mateo biotech building long-acting antibody-peptide conjugates that go after obesity by neutralizing the GIP hormone in the bloodstream rather than blocking its receptor. With nearly three decades of company-building behind him - CEO roles at Initial Therapeutics and Second Genome, business and strategy chief at Sonoma Biotherapeutics, and time as an Entrepreneur-in-Residence at Third Rock Ventures - he is the operator brought in to turn a $65M Series A and a clinic-ready antibody into medicines that aim for quarterly dosing and better-quality weight loss.
Sami Inkinen
Sami Inkinen is a Finnish-born, Stanford-trained entrepreneur and the co-founder and CEO of Virta Health, a company on a mission to reverse metabolic disease in one billion people through nutrition, technology, and AI. He earlier co-founded the real estate marketplace Trulia, taking it public in 2012 before its merger with Zillow. A self-described 'incurable data geek' and world-class endurance athlete, he is a triathlon age-group world champion and, in 2014, rowed 2,750 miles unsupported across the Pacific from California to Hawaii with his wife in a record-setting 45 days to raise awareness about sugar and metabolic disease.
Joe Murad
Joe Murad is President and CEO of Vida Health, a San Francisco-based virtual care company. A two-decade healthcare technology operator, he previously ran WithMe Health and PokitDok (acquired by Change Healthcare), with earlier leadership roles at Willis Towers Watson, Extend Health, and eHealth.